Cymed Ostomy
Generated 5/10/2026
Executive Summary
Cymed Ostomy is a privately held U.S. medical device company specializing in ostomy care products, with a focus on its proprietary MicroSkin® adhesive barrier technology. Founded in 2003 and headquartered in Portland, Oregon, the company serves individuals with ileostomies, colostomies, and urostomies. Its core product line leverages a thin, stretchable, hypoallergenic polyurethane film that provides a secure yet gentle seal, enhancing comfort and durability for daily use. Despite a lack of disclosed funding or valuation, Cymed Ostomy has established a niche in the ostomy market by differentiating its products through superior skin-friendliness and flexibility compared to traditional hydrocolloid-based barriers. The company operates in the competitive medical devices category and is listed on biopharmguy.com, indicating active presence in the industry.
Upcoming Catalysts (preview)
- Q3 2026Launch of next-generation MicroSkin pouch with enhanced adhesion70% success
- Q4 2026Partnership with major hospital group for distribution expansion50% success
- Q2 2026FDA 510(k) clearance for extended-wear urostomy pouch65% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)